东南亚制药行业市场前景及投资研究报告-培训课件外文版2024.4

INDUSTRIES

&

MARKETSPharmaceuticalindustryinSoutheastAsiaCHAPTER

01OverviewRevenueoftheworldwidepharmaceuticalmarketfrom2001to2023(inbillionU.S.dollars)Pharmaceuticalmarket:worldwiderevenue2001-20231,8001,6001,4001,2001,0001,6071,4821,4501,3121,2781,2141,1351,1161,064

1,073994963

96488883179980072664960156060040020004984283902001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

20233/statistics/263102/pharmaceutical-market-worldwide-revenue-since-2001Theglobalpharmaceuticalmarkethasexperiencedsignificantgrowthinrecentyears.For2023,thetotalglobalpharmaceuticalmarketwasestimatedataround1.6trillionU.S.dollars.Thisisanincreaseofover100billiondollarscomparedto2022.

ReadmoreNote(s):WorldwideSource(s):IQVIAWorldpharmaceuticalmarketrevenuein2022,byregion(inbillionU.S.dollars)Regionalpharmaceuticalmarketrevenueworldwide20227006005004003002001000666.2304.5304.256.2NorthAmericaAsia,Africa,AustralasiaEuropeanUnionLatinAmerica4Description:Thisstatisticshowstheregionalrevenuesontheworldpharmaceuticalmarketin2022.Inthatyear,LatinAmerica'spharmaceuticalrevenuecametosome56billionU.S.dollarsintotal.TheNorthAmericanpharmaceuticalmarketbyfarremainstheworld'slargestregionalmarket.ReadmoreNote(s):WorldwideSource(s):BPI;IQVIADistributionofglobalpharmaceuticalmarketrevenuefrom2010to2022,byregionGlobalpharmaceuticalmarket-revenuedistribution2010-2022,byregionNorthAmerica(U.S.,Canada)Europe*Africa,Asia&Australia**ChinaJapanLatinAmerica60%50%40%30%20%10%0%20102011201220132014201520162017201820192020202120225Description:In2022,theNorthAmericanregionaccountedforoverhalfofthepharmaceuticalmarketrevenueworldwide.Since2010,NorthAmerica`srevenuesharehasincreasedby10percent,whileJapan`ssharehasdecreasedbynearlysixpercent.

ReadmoreNote(s):WorldwideSource(s):EFPIA;IQVIAProjectedglobalpharmaceuticalmarketgrowthbetween2023and2027,byregionWorldpharmaceuticalmarketgrowthbyregion2023-20272022-2026CAGRLatinAmerica22%Europenon-EU(incl.UK)10.6%Indiansubcontinent9.5%NorthAmerica7.8%MiddleEast6.6%6.3%6.2%5.9%CommonwealthofIndependentStatesEUAfricaSoutheast&EastAsiaOceania4.8%3.9%3.9%ChinaJapan0.3%6Description:Thisstatisticdescribestheprojectedglobalpharmaceuticalmarketgrowthfortheperiod2023-2027,bycompoundannualgrowthrate(CAGR)andbyregionalsubmarkets.ItisexpectedthatNorthAmericawillgrowataCAGRof7.8percentinthegivenperiod.Interestingly,ChinaisprojectedtohaveoneofthelowestCAGRsintheprovidedperiod.ReadmoreNote(s):Worldwide;asof2023Source(s):AstraZeneca;IQVIADistributionofpharmaceuticalR&Dcompaniesworldwidebycountryasof2023DistributionofpharmaceuticalR&Dcompaniesbyregion2023ShareofR&DcompaniesUnitedStatesRestofEuropeChina43%15%13%RestofAsiaPacificUnitedKingdomCanada11%5%4%3%3%2%1%JapanFranceGermanyLatinAmericaandAfrica7Description:ThisstatisticshowsthedistributionofpharmaceuticalR&Dcompaniesworldwidebycountryorregion,asofJanuary2023.Asofthatmoment,43percentofallpharmaceuticalR&DcompanieswereheadquarteredintheUnitedStates.

ReadmoreNote(s):Worldwide;asofJanuary2023Source(s):PharmaIntelligence(Citeline)CHAPTER

02SEAoverviewRevenueofthepharmaceuticalmarketinSoutheastAsiafrom2019to2023,withforecaststo2028(inbillionU.S.dollars)PharmamarketrevenueSEA2019-20281817.0615.9715.9915.9216141210814.8814.0113.412.7510.169.956420201920202021202220232024*2025*2026*2027*2028*9Description:In2023,thepharmaceuticalmarketrevenueinSoutheastAsiaamountedtoabout12.8billionU.S.dollars.Theregion'spharmamarketwasestimatedtoreachanewpeakofaround17.1billiondollarsinrevenuein2028.

ReadmoreNote(s):Asia;2019to2023;*ForecastDataprovidedbyMarketInsightsareestimates.ThePharmaceuticalsmarketcoversremediesusedtocure,treat,prevent,anddiagnosediseases.Thesesmallmoleculedrugsorbiologicmedical[...]

ReadmoreSource(s):GrowthrateofthepharmaceuticalmarketinSoutheastAsiafrom2019to2023,withforecaststo2028PharmamarketgrowthrateSEA2019-202865%57.19%55%45%35%25%15%7%7.18%2028*6.2%5.11%2024*4.23%4.56%2025*2.07%20205%-5%0.13%2022-15%-25%-20.28%2023201920212026*2027*10Description:TherevenuechangeinthepharmaceuticalsmarketinSoutheastAsiawasforecasttocontinuouslyincreasebetween2024and2028byintotal2.1percentagepoints.Accordingtothisforecastin2028,theindicatorwillhaveincreasedforthethirdconsecutiveyearto7.18percent.ReadmoreNote(s):Asia;2019to2023;*ForecastDataprovidedbyMarketInsightsareestimates.ThePharmaceuticalsmarketcoversremediesusedtocure,treat,prevent,anddiagnosediseases.Thesesmallmoleculedrugsorbiologicmedical[...]

ReadmoreSource(s):PharmaceuticalmarketrevenueinSoutheastAsiafrom2019to2023,withforecaststo2028,bysegment(inmillionU.S.dollars)PharmamarketrevenueSEA2019-2028,bysegmentOncologyDrugsAntiviralDrugsAnti-CoagulantsAnti-DiabetesDrugsImmunosuppressantsAnti-FibrinolyticsDrugsAnti-RheumaticDrugsBronchodilatorDrugsMultipleSclerosisDrugsVaccinesSensoryOrgansDrugsLipid-LoweringAgentsDermatologicalDrugsAnti-HypertensiveDrugsOtherPharmaceuticals18,00016,00014,00012,00010,0008,0006,0004,0002,0000201920202021202220232024*2025*2026*2027*2028*11Description:In2023,thepharmaceuticalindustryinSoutheastAsiageneratedapproximately12.74billionU.S.dollarsinrevenue.Oncologydrugsaccountedforaround2.1billiondollarsinrevenuethatyear.ReadmoreNote(s):Asia;2019to2023;*ForecastDataprovidedbyMarketInsightsareestimates.ThePharmaceuticalsmarketcoversremediesusedtocure,treat,prevent,anddiagnosediseases.Thesesmallmoleculedrugsorbiologicmedical[...]

ReadmoreSource(s):RevenueofthepharmaceuticalmarketinSoutheastAsiafrom2019to2023,withforecaststo2028,bycountry(inmillionU.S.dollars)PharmalmarketrevenueSEA2019-2028,bycountryIndonesiaMalaysiaPhilippinesSingaporeThailandVietnam18,00016,00014,00012,00010,0008,0006,0004,0002,0000201920202021202220232024*2025*2026*2027*2028*12Description:In2023,SoutheastAsia'spharmaceuticalmarketgeneratedaround12.25billionU.S.dollars,markingadecreasefromover15billiondollarsinthepreviousyear.Indonesiaisthebiggestpharmaceuticalmarketintheregion,havinggeneratedapproximately3.35billiondollarsin2023.ReadmoreNote(s):Indonesia,Malaysia,Philippines,Singapore,Vietnam,Thailand;2019to2023Source(s):CHAPTER

03OTCpharmaceuticalsRevenueoftheOTCpharmaceuticalsmarketinSoutheastAsiafrom2019to2023,withforecaststo2028(inbillionU.S.dollars)OTCpharmamarketrevenueSEA2019-20281411.891211.1910.489.81089.178.557.987.357.347.026420201920202021202220232024*2025*2026*2027*2028*14Description:TherevenueintheotcpharmaceuticalsmarketinSoutheastAsiawasforecasttocontinuouslyincreasebetween2024and2028byintotal2.7billionU.S.dollars(+29.44percent).Aftertheseventhconsecutiveincreasingyear,theindicatorisestimatedtoreach11.89billionU.S.dollarsandthereforeanewpeakin2028.ReadmoreNote(s):Asia;2019to2023;*ForecastDataprovidedbyMarketInsightsareestimates.Definition:TheOver-the-CounterPharmaceuticalsmarketincludesnon-prescriptionmedications,treatments,andhealthcareproductsthatare[...]

ReadmoreSource(s):GrowthrateoftheOTCpharmaceuticalmarketinSoutheastAsiafromto2019to2023,withforecaststo2028OTCpharmamarketgrowthrateSEA2019-202810%8.71%9%8%7%6%5%4%3%2%1%0%-1%7.46%7.22%7.22%6.88%6.88%6.76%6.34%4.7%-0.14%202120192020202220232024*2025*2026*2027*2028*15Description:TherevenuechangeintheotcpharmaceuticalsmarketinSoutheastAsiawasforecasttocontinuouslydecreasebetween2024and2028byintotal0.9percentagepoints.Theindicatorisestimatedtoamountto6.34percentin2028.

ReadmoreNote(s):Asia;2019to2023;*ForecastDataprovidedbyMarketInsightsareestimates.Definition:TheOver-the-CounterPharmaceuticalsmarketincludesnon-prescriptionmedications,treatments,andhealthcareproductsthatare[...]

ReadmoreSource(s):RevenueoftheOTCpharmaceuticalsmarketinSoutheastAsiafrom2019to2023,withforecaststo2028,bysegment(inmillionU.S.dollars)OTCpharmamarketrevenueSEA2019-2028,bysegmentAnalgesicsVitamins&MineralsWoundCareCold&CoughRemediesHandSanitizerOtherOTCPharmaceuticalsDigestives&IntestinalRemediesEyeCareSkinTreatmentSleepAids14,00012,00010,0008,0006,0004,0002,0000201920202021202220232024*2025*2026*2027*2028*16Description:Therevenueisforecasttoexperiencesignificantgrowthinallsegmentsin2028.Comparingthetendifferentsegmentsfortheyear2028,thesegment'Vitamins&Minerals'leadstherankingwith2.9billionU.S.dollars.Contrastingly,'WoundCare'isrankedlast,with85.9millionU.S.dollars.Theirdifference,comparedtoVitamins&Minerals,liesat2.8billionU.S.dollars.ReadmoreNote(s):Asia;2019to2023;*ForecastDataprovidedbyMarketInsightsareestimates.Definition:TheOver-the-CounterPharmaceuticalsmarketincludesnon-prescriptionmedications,treatments,andhealthcareproductsthatare[...]

ReadmoreSource(s):RevenueoftheOTCpharmaceuticalsmarketinSoutheastAsiafrom2016to2023,withforecaststo2028,bycountry(inmillionU.S.dollars)OTCpharmamarketrevenueSEA2016-2028,bycountryBruneiCambodiaIndonesiaLaosMalaysiaMyanmarPhilippinesSingaporeThailandTimor-LesteVietnam14,00012,00010,0008,0006,0004,0002,0000201620172018201920202021202220232024202520262027202817Description:Therevenueisforecasttoexperiencesignificantgrowthinallregionsin2028.Fromtheselectedregions,therankingbyrevenueintheotcpharmaceuticalsmarketisforecasttobeleadbyIndonesiawith4.1billionU.S.dollars.Incontrast,therankingistrailedbyTimor-Lestewith6.84millionU.S.dollars,recordingadifferenceof4.1billionU.S.dollarstoIndonesia.ReadmoreNote(s):Brunei,Myanmar[Burma],Cambodia,Indonesia,Laos,Malaysia,Philippines,Timor-Leste,Singapore,Vietnam,Thailand;2016to2023;*ForecastDataprovidedbyMarketInsightsareestimates.Definition:TheOver-the-Counter[...]

ReadmoreSource(s):CHAPTER

04InternationaltradeTradebalanceofpharmaceuticalproductsinSoutheastAsiain2022,bycountry(inmillionU.S.dollars)PharmatradebalanceSEA2022,bycountryTradebalanceinmillionU.S.dollarsSingaporeTimor-LesteLaos5,070.56-13.26-82.99-141BruneiCambodiaMyanmarIndonesiaMalaysiaVietnam-356.9-605.09-909.99-1,753-2,547.29-2,630.82PhilippinesThailand-3,095.6519Description:In2022,SingaporehadapharmaceuticalproducttradebalanceofapproximatelyfivebillionU.S.dollars.Thatyear,SingaporewastheonlycountryinSoutheastAsiawithatradesurplusforpharmaceuticalproducts.Incontrast,Thailandhadthebiggestpharmaceuticaltradedeficitatoverthreebilliondollars.ReadmoreNote(s):Asia;2022Source(s):TradeMap;UNComtradeImportvalueofpharmaceuticalproductsinSoutheastAsiain2022,bycountry(inmillionU.S.dollars)ImportvalueofpharmaceuticalsSEA2022,bycountryImportvalueinmillionU.S.dollars2,000

3,00001,0004,0005,0006,000SingaporeThailandVietnamPhilippinesMalaysiaIndonesiaMyanmarCambodiaBrunei5,181.73,516.432,796.242,703.682,220.291,511.57603.96368.4142.8279.52LaosTimor-Leste

13.2620Description:In2022,thevalueofpharmaceuticalimportstoSingaporeamountedtoapproximately5.18billionU.S.dollars.Thailandfollowedwithapharmaceuticalimportvalueofaround3.52billiondollars.ReadmoreNote(s):Asia;2022Source(s):TradeMap;UNComtradeExportvalueofpharmaceuticalproductsinSoutheastAsiain2022,bycountry(inmillionU.S.dollars)ExportvalueofpharmaceuticalsSEA2022,bycountryExportvalueinmillionU.S.dollars4,000

5,000

6,00001,0002,0003,0007,0008,0009,00010,0009,842.8311,000SingaporeIndonesiaThailand643.57620.23MalaysiaVietnam468.91248.9572.86PhilippinesCambodia

18.87Brunei

1.82Laos

0.38Myanmar

0.0521Description:Asof2022,thevalueofpharmaceuticalexportsfromSingaporeamountedtoapproximately9.8billionU.S.dollars,thehighestamongSoutheastAsiancountries.Indonesiafollowedwithapharmaexportvalueofaround643.6milliondollars.

ReadmoreNote(s):Asia;2022Source(s):TradeMap;UNComtradeCHAPTER

05ClinicaltrialsNumberofclinicaltrialsconductedinSoutheastAsiabetween1999and2022,bycountryNumberofclinicaltrialsSEA1999-2022,bycountryNumberoftrials6,00002,0004,0008,00010,00012,000ThailandSingaporeMalaysiaPhilippinesVietnam11,0364,6733,4172,2451,3061,253IndonesiaCambodiaMyanmarLaos17411286Brunei

38Timor-Leste

2523Description:Between1999and2022,over11thousandclinicaltrialswereconductedinThailand,byfarthehighestnumberacrossSoutheastAsia.Singaporefollowed,witharound4.67thousandclinicaltrialsconductedduringthistimeperiod.ReadmoreNote(s):Asia;1999to2022Source(s):WHOShareofclinicaltrialsconductedinselectedcountriesinSoutheastAsiabetween1999and2022,byhealthcategoryShareofclinicaltrialsinselectedcountriesSEA1999-2022,byhealthcategoryNon-communicablediseases2%Communicable,maternal,perinatal,andnutritionalconditionsInjuries1%Others100%90%80%70%60%50%40%30%20%10%0%1%1%1%1%4%3%12%19%15%23%34%39%86%82%81%72%65%57%SingaporeMalaysiaPhilippinesThailandVietnamIndonesia24Description:Between1999and2022,over11thousandclinicaltrialswereconductedinThailand,thehighestnumberacrossSoutheastAsia.Outofthese,72percentweretrialstestingpharmaproductsforbattlingnon-communicablediseases.

ReadmoreNote(s):Asia;1999to2022Source(s):WHOCHAPTER

06ConsumerperspectivePreferredchannelsforpurchasingprescribedmedicinesinSoutheastAsiaasofJanuary2023,bycountryPreferredchannelsformedicinepurchasesSEA2023,bycountryShareofrespondentsPhysicalstoresandpharmaciesOnlinestores60%0%10%20%30%40%50%70%80%90%100%VietnamPhilippinesThailand97.37%2.63%97.22%94.96%2.78%5.04%Malaysia93.54%6.46%Indonesia88.46%11.54%27Description:Accordingtoa2023surveyconductedinSoutheastAsia,avastmajorityofrespondentsacrossallparticipatingcountriesstatedthattheygenerallypurchasedprescribedmedicinesinphysicalstoresandpharmacies.

ReadmoreNote(s):January2023;18yearsandolderSource(s):StandardInsightsPreferredproductsandservicespurchasedforhealthandwellnessinSoutheastAsiaasofJanuary2023,bycountryMostpopularhealthandwellnessproductsandservicesSEA2023,bycountryIndonesia49%Malaysia57.34%29.55%51.27%Philippines75.82%Thailand42.25%17.44%46.12%Vietnam57.4%17%VitaminsupplementsFitnesssupplements6.41%25.33%Personalcareitems(bathsoap,moisturizers,etc.)21.79%63.24%40.9%ServicesofanaestheticianServicesofapersonalfitnesstrainerExerciseequipmentandmachinesNoneoftheabove3.7%3.56%9.54%5.56%0.43%9.98%17.42%36.79%8.02%10.13%13.4%35.29%0.49%4.9%12.4%5.62%8.2%9.1%23.26%14.92%0.19%28.9%15.4%0.5%Other0.39%28Description